- Home
- GHRS vs GAM Comparison
GHRS vs GAM Comparison
Compare GHRS & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHRS | GAM |
|---|---|---|
| Founded | 2018 | 1927 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GHRS | GAM |
|---|---|---|
| Price | $28.96 | $64.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $41.38 | N/A |
| AVG Volume (30 Days) | ★ 233.7K | 28.1K |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.74% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 11.67 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.32 | $56.24 |
| 52 Week High | $31.00 | $66.18 |
Technical Indicators
Market Signals| Indicator | GHRS | GAM |
|---|---|---|
| Relative Strength Index (RSI) | 65.84 | 52.33 |
| Support Level | $12.88 | $62.27 |
| Resistance Level | $28.96 | $64.60 |
| Average True Range (ATR) | 1.66 | 0.66 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 65.92 | 68.53 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations. The company invests principally in common stocks believed by management to have growth potential.